Literature DB >> 28385899

Response to "Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids".

Jason W Busse1, David Juurlink2, Gordon H Guyatt3.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28385899      PMCID： PMC5378514          DOI： 10.1503/cmaj.732910

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids.

Authors:  H M Oetter
Journal:  CMAJ       Date:  2017-04-03       Impact factor: 8.262

2.  Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain.

Authors:  Jason W Busse; David Juurlink; Gordon H Guyatt
Journal:  CMAJ       Date:  2016-11-21       Impact factor: 8.262
  2 in total
  2 in total

1.  Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.

Authors:  Stephanie Parent; Seonaid Nolan; Nadia Fairbairn; Monica Ye; Anthony Wu; Julio Montaner; Rolando Barrios; Lianping Ti
Journal:  Int J Drug Policy       Date:  2019-03-18

2.  The authors respond to "The 2017 Canadian opioid guideline: already time for an overhaul".

Authors:  Jason W Busse; David Juurlink; D Norman Buckley; Gordon H Guyatt
Journal:  CMAJ       Date:  2018-03-12       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.